摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-甲基3-氰基哒嗪 | 106861-17-0

中文名称
4-甲基3-氰基哒嗪
中文别名
——
英文名称
3-carbonitrile-4-methyl-1,2-pyridazine
英文别名
4-methylpyridazine-3-carbonitrile
4-甲基3-氰基哒嗪化学式
CAS
106861-17-0
化学式
C6H5N3
mdl
——
分子量
119.126
InChiKey
XVOXNSDLOXACCF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    43-44 °C
  • 沸点:
    320.2±22.0 °C(Predicted)
  • 密度:
    1.16±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    49.6
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933990090
  • 危险性防范说明:
    P261,P280,P301+P310,P311
  • 危险性描述:
    H302

SDS

SDS:9da43a36e2a0efc4cfdbf814e5dedf5d
查看

反应信息

点击查看最新优质反应信息

文献信息

  • N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
    申请人:Rodgers James D.
    公开号:US20100298334A1
    公开(公告)日:2010-11-25
    The present invention relates to N-(hetero)aryl-pyrrolidine derivatives of Formula I: which are JAK inhibitors, such as selective JAK1 inhibitors, useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
    本发明涉及式I的N-(杂)芳基吡咯烷衍生物: 这些是JAK抑制剂,如选择性JAK1抑制剂,在治疗JAK相关疾病方面具有用处,例如炎症和自身免疫性疾病,以及癌症。
  • 4-ALKOXY/ARALKOXY-5-SUBSTITUTED-PYRROLOPYRIMIDINE COMPOUNDS AS TAK1 INHIBITORS IN DISEASE TREATMENT
    申请人:Confluence Life Sciences Inc.
    公开号:US20150203499A1
    公开(公告)日:2015-07-23
    The present disclosure provides 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds, pharmaceutically acceptable salts, solvates and pharmaceutical compositions of compounds embraced by Formula (I), providing a therapeutic benefit to subjects with disease conditions, especially cancer, wherein R 1 and R 2 are as defined in the detailed description.
    本公开提供4-烷氧基/芳氧基-5-取代-吡咯嘧啶化合物、药学上可接受的盐、溶剂和由式(I)所包含的化合物组成的制药组合物,为患有疾病情况的受试者提供治疗益处,特别是癌症,其中R1和R2如详细说明中所定义。
  • Efficient synthesis of 5-substituted-3-pyridazine carbonitrile via regioselective Reissert-type reaction
    作者:Shengqiang Wang、Zhiyue Geng、Ruiyun Guo、Jingya Li、Dapeng Zou、Yangjie Wu、Yusheng Wu
    DOI:10.1016/j.tetlet.2016.05.037
    日期:2016.7
    Various 5-substituted-3-pyridazine carbonitrile derivatives were synthesized by regioselective Reissert-type reaction with 4-substituted pyridazine, 4-methylbenzene-1-sulfonyl chloride and trimethylsilyl cyanide. The reaction can be carried out under conditions of AlCl3 as catalyst, THF as solvent at 10 degrees C, followed by treatment with DBU which gave moderate yields and good regioselectivity. (C) 2016 Elsevier Ltd. All rights reserved.
  • DOSTAL W HEINISCH G., HETEROCYCLES, 24,(1986) N 4, 793-797
    作者:DOSTAL W HEINISCH G.
    DOI:——
    日期:——
  • US8716303B2
    申请人:——
    公开号:US8716303B2
    公开(公告)日:2014-05-06
查看更多